BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7774645)

  • 1. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
    Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
    J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation.
    Jabado N; Pallier A; Le Deist F; Bernard F; Fischer A; Hivroz C
    J Immunol; 1997 Jan; 158(1):94-103. PubMed ID: 8977179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase.
    Deans JP; Kanner SB; Torres RM; Ledbetter JA
    Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLP-76 binding to p56lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex.
    Sanzenbacher R; Kabelitz D; Janssen O
    J Immunol; 1999 Sep; 163(6):3143-52. PubMed ID: 10477581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120.
    Horak ID; Popovic M; Horak EM; Lucas PJ; Gress RE; June CH; Bolen JB
    Nature; 1990 Dec; 348(6301):557-60. PubMed ID: 1701034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tyrosine kinase activation blocks the down-regulation of CXC chemokine receptor 4 by HIV-1 gp120 in CD4+ T cells.
    Su SB; Gong W; Grimm M; Utsunomiya I; Sargeant R; Oppenheim JJ; Ming Wang J
    J Immunol; 1999 Jun; 162(12):7128-32. PubMed ID: 10358157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.
    Danielian S; Alcover A; Polissard L; Stefanescu M; Acuto O; Fischer S; Fagard R
    Eur J Immunol; 1992 Nov; 22(11):2915-21. PubMed ID: 1358625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation.
    Goldman F; Jensen WA; Johnson GL; Heasley L; Cambier JC
    J Immunol; 1994 Oct; 153(7):2905-17. PubMed ID: 7522245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-independent signal transduction through the T-cell receptor (TCR/CD3).
    Granja CB; Gozashti CS; Dasgupta JD
    Immunology; 1994 Nov; 83(3):414-9. PubMed ID: 7835966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engagement of the CD4 receptor inhibits the interleukin-2-dependent proliferation of human T cells transformed by Herpesvirus saimiri.
    Bröker BM; Tsygankov AY; Fickenscher H; Chitaev NA; Müller-Fleckenstein I; Fleckenstein B; Bolen JB; Emmrich F; Schulze-Koops H
    Eur J Immunol; 1994 Apr; 24(4):843-50. PubMed ID: 8149955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequestration of p56(lck) by gp120, a model for TCR desensitization.
    Goldman F; Crabtree J; Hollenback C; Koretzky G
    J Immunol; 1997 Mar; 158(5):2017-24. PubMed ID: 9036944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.